Perhaps nowhere else in dermatology is so little known about a disorder that affects so many. Because the cause of rosacea is unknown and there is no cure, the National Rosacea Society's research grants program was established in 1999 to encourage and support research into the potential causes and other key aspects of this disorder that may lead to improvements in its treatment and potential prevention or cure. Since its founding, the research grants program has awarded more than $1.7 million to researchers for a wide range of rosacea-related studies, and the program is funded by donations from many thousands of individuals who wish to improve the lives of those affected by rosacea. Join the fight against rosacea. Donate to this important program today.
To apply for a research grant, click here. Grants are available to researchers worldwide.
Awarded Grants
Grants for 75 studies have been awarded to date, and have led to further investigations in such promising areas as the immune system, nervous systems, facial blood vessels, microbes, Demodex mites and genetics.
Research Results
As studies funded by the National Rosacea Society are completed, reports on results are published on this site and in Rosacea Review.
Medical Advisory Board
Grant applications are reviewed and selected for funding by the Society's medical advisory board, composed of leading experts on rosacea.
| Dr. Richard Granstein, Chairman Chairman of Dermatology Weill Cornell Medical College | Emeritus Members Dr. Jonathan Wilkin Former Director, Dermatologic and Dental Drug Products Food and Drug Administration |
| Dr. Hilary Baldwin Associate Professor of Dermatology Rutgers Robert Wood Johnson Medical School | Dr. Mark Dahl Professor Emeritus The Mayo Clinic College of Medicine (former AAD president) |
| Dr. Richard Gallo Chairman of Dermatology University of California - San Diego | Dr. Michael Detmar Professor of Pharmacogenomics Federal Institute of Technology Zurich, Switzerland |
| Dr. Julie Harper President and Owner Dermatology and Skin Care Center of Birmingham | Dr. Lynn Drake Harvard Medical School (former AAD president) |
| Dr. Yolanda Helfrich Professor of Dermatology University of Michigan | Dr. Marian Macsai Professor of Ophthalmology University of Chicago |
| Dr. Sewon Kang Chairman of Dermatology Johns Hopkins University School of Medicine | Dr. Richard Odom Professor of Clinical Dermatology University of California - San Francisco (former AAD president) |
| Dr. Mark Mannis Chairman of Ophthalmology University of California-Davis | Dr. Frank Powell Consultant Dermatologist Regional Centre of Dermatology Mater Misericordiae Hospital Dublin, Ireland |
| Dr. Martin Steinhoff Chairman of Dermatology Director, Charles Institute of Dermatology University College, Dublin | Dr. Diane Thiboutot Professor of Dermatology Pennsylvania State University |
Classification of Rosacea
A standard classification system was developed and published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research, improve clinical diagnosis and provide common terminology for communications. It can be viewed online here.
Grading of Rosacea
A standard grading system for rosacea was published by the National Rosacea Society Expert Committee on the Classification and Staging of Rosacea to unify research and improve clinical assessment. It can be viewed online here.